抗胆固醇药物使用与肝硬化症患者肝硬化症风险之间的关联
Hsin-Ni Shih1, Chung-Hsuen Wu2, Yuan-Wen Lee3
1School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan; Department of Pharmacy Administration, Chang Gung Medical Foundation, Taoyuan, Taiwan.
概括
使用抗胆固醇药物显著增加肝硬化患者肝脏脑病变的风险. 建议对这些人进行仔细的处方和认知功能的监测.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 抗胆固醇药物可以改变肠道微生物群,可能导致肝硬化患者肝脏脑病变.
- 肠道失调与胃酸减少和便秘有关,这是抗胆固醇药物的常见副作用.
研究的目的:
- 调查抗胆固醇药物使用与肝脏脑病变风险之间的关联.
- 评估抗胆固醇药物对肝硬化患者健康结果的影响.
主要方法:
- 台湾10607名肝硬化患者的回顾性队列研究 (2007-2018).
- 根据连续处方补充,被归类为抗胆固醇药物使用者或非使用者的患者.
- 倾向性得分匹配和治疗权重的逆概率用于控制混因素.
主要成果:
- 抗胆固醇药物使用者占研究队列的33.8%.
- 在抗胆固醇药物使用者 (aHR: 2.59; 95% CI: 1.77-3.80) 中观察到肝脏脑病的风险显著增加.
结论:
- 抗胆固醇药物使用与肝硬化患者肝脏脑病变的风险较高有关.
- 在给肝硬化患者开抗胆固醇药物时,建议谨慎.
- 对使用这些药物的肝硬化患者来说,定期监测认知功能至关重要.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
847
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
847
Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
Hepatic Drug Excretion: Enterohepatic Cycling
1.8K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.8K
Factors Influencing Drug Absorption: Disease States and Pharmacology
830
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
830
Esophageal Varices-II: Clinical Features and Management
149
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
149
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
213
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
213


